Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on EquityReturn on SalesTimes Interest Earned

Exousia Bio (LMMY) Gross Margin (2023 - 2024)

Lamy (LMMY) has disclosed Gross Margin for 2 consecutive years, with 100.0% as the latest value for Q3 2024.

  • Quarterly Gross Margin changed N/A to 100.0% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 93.36% through May 2025, down 10930.0% year-over-year, with the annual reading at 93.36% for FY2025, 10930.0% down from the prior year.
  • Gross Margin hit 100.0% in Q3 2024 for Lamy, up from 157.79% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q4 2023 to a low of 157.79% in Q2 2024.